{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T03:03:38Z","timestamp":1791515018285,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017357","name":"Science and Technology Projects of Fujian Province","doi-asserted-by":"publisher","award":["2023Y9064"],"award-info":[{"award-number":["2023Y9064"]}],"id":[{"id":"10.13039\/100017357","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024J01532"],"award-info":[{"award-number":["2024J01532"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004749","name":"Xiamen Technology College","doi-asserted-by":"publisher","award":["3502Z20214ZD1065"],"award-info":[{"award-number":["3502Z20214ZD1065"]}],"id":[{"id":"10.13039\/501100004749","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Science"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jos.2026.02.016","type":"journal-article","created":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T13:17:40Z","timestamp":1774790260000},"page":"1157-1165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["BTK as a novel diagnostic biomarker and therapeutic target in osteosarcoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Jiude","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihsiang","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinluan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leiting","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miersalijiang","family":"Yasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jos.2026.02.016_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1490759","article-title":"Shikonin suppresses proliferation of osteosarcoma cells by inducing ferroptosis through promoting Nrf 2 ubiquitination and inhibiting the xCT\/GPX4 regulatory axis","volume":"15","author":"Huang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jos.2026.02.016_bib2","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s12964-024-01989-w","article-title":"New insights into the role of mitophagy related gene affecting the metastasis of osteosarcoma through scRNA-seq and CRISPR-Cas9 genome editing","volume":"22","author":"Zheng","year":"2024","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.jos.2026.02.016_bib3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1186\/s12885-024-13088-7","article-title":"Osteosarcoma cells depend on MCL-1 for survival, and osteosarcoma metastases respond to MCL-1 antagonism plus regorafenib in vivo","volume":"24","author":"Ji","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jos.2026.02.016_bib4","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2024.2391001","article-title":"Bone scaffolds-based localized drugs delivery for osteosarcoma: current status and future perspective","volume":"31","author":"Liang","year":"2024","journal-title":"Drug Deliv"},{"key":"10.1016\/j.jos.2026.02.016_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176009","article-title":"Butyrate enhances erastin-induced ferroptosis of osteosarcoma cells via regulating ATF3\/SLC7A11 pathway","volume":"957","author":"Nie","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jos.2026.02.016_bib6","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401508RR","article-title":"Inhibition of discoidin domain receptor 1 as a new therapeutic strategy for osteosarcoma","volume":"38","author":"Wang","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.jos.2026.02.016_bib7","article-title":"Phase II study of samotolisib in children and young adults with tumors harboring phosphoinositide 3-Kinase\/Mammalian target of rapamycin pathway alterations: pediatric MATCH APEC1621D","volume":"8","author":"Laetsch","year":"2024","journal-title":"JCO Precis Oncol"},{"issue":"2","key":"10.1016\/j.jos.2026.02.016_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2024.10.035","article-title":"Bruton\u2019s tyrosine kinase (BTK) and matrix metalloproteinase-9 (MMP-9) regulate NLRP3 inflammasome-dependent cytokine and neutrophil extracellular trap responses in primary neutrophils","volume":"155","author":"Leal","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jos.2026.02.016_bib9","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13046-017-0600-7","article-title":"High expression of Bruton's tyrosine kinase (BTK) is required for EGFR-Induced NF-kappaB activation and predicts poor prognosis in human glioma","volume":"36","author":"Yue","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jos.2026.02.016_bib10","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1007\/s00262-023-03497-1","article-title":"BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy","volume":"72","author":"Sun","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"4","key":"10.1016\/j.jos.2026.02.016_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00216-024-05701-2","article-title":"Development, validation, and clinical application of LC-MS\/MS method for simultaneous determination of ibrutinib, zanubrutinib, orelabrutinib, acalabrutinib, and their active metabolites in patients with B-cell lymphoma","volume":"417","author":"Jiang","year":"2025","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.jos.2026.02.016_bib12","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1038\/onc.2015.504","article-title":"A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation","volume":"35","author":"Grassilli","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.jos.2026.02.016_bib13","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s10637-019-00837-w","article-title":"Ibrutinib as a potential therapeutic option for HER2 overexpressing breast cancer - the role of STAT3 and p21","volume":"38","author":"Prabaharan","year":"2020","journal-title":"Invest N Drugs"},{"key":"10.1016\/j.jos.2026.02.016_bib14","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1186\/s12885-025-14431-2","article-title":"NHP2 and PRPF4 are hub genes associated with the prognosis of colorectal cancer","volume":"25","author":"Li","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jos.2026.02.016_bib15","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202402011R","article-title":"Developing a 3D bone model of osteosarcoma to investigate cancer mechanisms and evaluate treatments","volume":"38","author":"Smith","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.jos.2026.02.016_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s13046-024-03249-8","article-title":"OTULIN confers cisplatin resistance in osteosarcoma by mediating GPX4 protein homeostasis to evade the mitochondrial apoptotic pathway","volume":"43","author":"Zheng","year":"2024","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jos.2026.02.016_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jaci.2024.03.003","article-title":"Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia","volume":"154","author":"Bahal","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jos.2026.02.016_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/hon.70001","article-title":"Ibrutinib with bendamustine and rituximab for treatment of patients with relapsed\/refractory aggressive B-Cell lymphoma","volume":"42","author":"Kedmi","year":"2024","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jos.2026.02.016_bib19","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.95488","article-title":"Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia","volume":"13","author":"Joseph","year":"2024","journal-title":"eLife"},{"key":"10.1016\/j.jos.2026.02.016_bib20","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8007","article-title":"Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPA-induced breast cancer cell invasion via PLCgamma2\/PKCbeta\/NF-kappaB\/AP-1-dependent matrix metalloproteinase-9 activation","volume":"45","author":"Kim","year":"2021","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jos.2026.02.016_bib21","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1158\/1535-7163.MCT-15-0813","article-title":"Bruton's tyrosine kinase inhibitors prevent therapeutic escape in breast cancer cells","volume":"15","author":"Wang","year":"2016","journal-title":"Mol Cancer Therapeut"},{"key":"10.1016\/j.jos.2026.02.016_bib22","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1080\/15384047.2015.1078023","article-title":"Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer","volume":"16","author":"Kokabee","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jos.2026.02.016_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s13046-017-0549-6","article-title":"Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma","volume":"36","author":"Wang","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.jos.2026.02.016_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1476030","article-title":"NF-kappaB signaling pathway in tumor microenvironment","volume":"15","author":"Cao","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jos.2026.02.016_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168621","article-title":"Divergent processing of cell stress signals as the basis of cancer progression: licensing NFkappaB on chromatin","volume":"25","author":"Vlahopoulos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jos.2026.02.016_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113313","article-title":"Zanubrutinib ameliorates experimental idiopathic inflammatory myopathy-associated interstitial lung disease by BTK\/NF-kappaB signaling pathway","volume":"143","author":"Liu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jos.2026.02.016_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.151583","article-title":"Loss of ATRX promotes aggressive features of osteosarcoma with increased NF-kappaB signaling and integrin binding","volume":"7","author":"Bartholf DeWitt","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jos.2026.02.016_bib28","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.24976\/Discov.Med.202436187.151","article-title":"Baicalin plays an anti-osteosarcoma role in vitro and promotes osteogenic differentiation by inhibiting NF-kappaB signaling","volume":"36","author":"Zhao","year":"2024","journal-title":"Discov Med"},{"key":"10.1016\/j.jos.2026.02.016_bib29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1515\/hsz-2020-0394","article-title":"SRPK1 promotes cell proliferation and tumor growth of osteosarcoma through activation of the NF-kappaB signaling pathway","volume":"403","author":"Gong","year":"2022","journal-title":"Biol Chem"}],"container-title":["Journal of Orthopaedic Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265826000837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0949265826000837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:10:35Z","timestamp":1788984635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0949265826000837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0949265826000837"],"URL":"https:\/\/doi.org\/10.1016\/j.jos.2026.02.016","relation":{},"ISSN":["0949-2658"],"issn-type":[{"value":"0949-2658","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BTK as a novel diagnostic biomarker and therapeutic target in osteosarcoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jos.2026.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}